ClinicalTrials.Veeva

Menu

Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent

A

Asan Medical Center

Status and phase

Unknown
Phase 1

Conditions

Healthy

Treatments

Drug: Indobufen

Study type

Interventional

Funder types

Other

Identifiers

NCT01232023
2009-0103

Details and patient eligibility

About

This study is designed to evaluate the pharmacokinetic and pharmacodynamic characteristics of indobufen in healthy subjects.

Enrollment

12 estimated patients

Sex

Male

Ages

19 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult males aged 19 to 50 years at screening.
  • Subjects with body weight ≥ 45 kg and within ±20% of the ideal body weight : Ideal body weight = (height [cm] - 100)x0.9.
  • Subjects who have received and understood completely the information regarding the current study and given written informed consents to voluntarily participate in the study and followed all instructions specified in the protocol.

Exclusion criteria

  • Subjects who have drunken habitually (exceeding 21 units/week, 1 unit = 10 g of pure alcohol) or who are unable to abstain from drinking during the study period from 2 days prior to the first administration of investigational product and during this study.
  • Subjects deemed ineligible by investigator based on other reasons, including abnormal laboratory values or diseases.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

12 participants in 4 patient groups

100mg
Experimental group
Description:
Wild type UGT1A : 3 / Variant type UGT1A : 3
Treatment:
Drug: Indobufen
200mg
Experimental group
Description:
Wild type UGT1A : 3 / Variant type UGT1A : 3
Treatment:
Drug: Indobufen
400mg
Experimental group
Description:
Wild type UGT1A : 3 / Variant type UGT1A : 3
Treatment:
Drug: Indobufen
800mg
Experimental group
Description:
Wild type UGT1A : 3 / Variant type UGT1A : 3
Treatment:
Drug: Indobufen

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems